Previous studies suggested that the activated PI3K/AKT/mTOR signaling pathway can promote cell survival and cancer cell growth by attenuating apoptosis-related signaling, and this effect can result in radiotherapy resistance [51]. This evidence concerns the gene AKT1 and cancer.